申请人:Yamanouchi Pharmaceutical Co., Ltd.
公开号:US05834460A1
公开(公告)日:1998-11-10
A serine derivative represented by the general formula (I) ##STR1## (symbols in the formula represent the following meanings; X: a sulfur atom or an oxygen atom, Y: a nitrogen atom or CH, R.sup.1 and R.sup.2 : the same or different from each other and each represents a hydrogen atom, a lower alkyl group or a protecting group for the amino group, or R.sup.1 and R.sup.2 may be combined together to form a four- to nine-membered nitrogen-containing cycloalkyl group, R.sup.3 : a hydrogen atom, a carboxyl group, a protected carboxyl group, an aralkyl group, or a lower alkyl group unsubstituted or substituted with a hydroxyl group, R.sup.4 : a hydrogen atom or a hydroxyl group, R.sup.5 : a hydrogen atom or a lower alkyl group, A: a lower alkylene group, B: 1) a saturated or unsaturated four- to ten-membered nitrogen-containing cycloalkyl group unsubstituted or substituted with a lower alkyl group or an aralkyl group or 2) a bicyclic nitrogen-containing hydrocarbon ring radical resulting from the condensation of a four- to eight-membered nitrogen-containing cycloalkyl group with a benzene ring, and . . : a single or double bond) or a pharmaceutically acceptable salt thereof, which has an anti-PCP (phencyclidine) action and is useful as a psychotropic drug.
一种丝氨酸衍生物,其通式表示为(I)##STR1##(式中的符号表示以下含义;X:硫原子或氧原子,Y:氮原子或CH,R.sup.1和R.sup.2:相同或不同,各代表氢原子、较低的烷基基团或氨基的保护基团,或R.sup.1和R.sup.2可以结合在一起形成含氮的四至九元环烷基基团,R.sup.3:氢原子、羧基、受保护的羧基、芳基烷基基团,或未取代或取代的含有羟基的较低的烷基基团,R.sup.4:氢原子或羟基,R.sup.5:氢原子或较低的烷基基团,A:较低的烷基烯基基团,B:1)未取代或取代的饱和或不饱和的含氮的四至十元环烷基基团或2)由含有四至八元含氮环烷基基团与苯环缩合而成的双环含氮碳氢环基团,以及. . :单键或双键)或其药用可接受盐,具有抗PCP(非那西定)作用,并且可用作精神药物。